Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application crawled time : 13:20 save search
SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China
Published: 2023-07-20 (Crawled : 13:20) - globenewswire.com
SCYX | $1.47 3.52% 3.4% 80K
|
Health Technology
|
| O: -0.36%
H: 6.43%
C: 6.07%
pharma drug application china
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in ChinaAcceptance of NDA Submission triggers as $2 million milestone payment to Ardelyx by Fosun Pharma
Published: 2023-07-13 (Crawled : 13:20) - biospace.com/
ARDX | News | $6.445 -1.6% -1.63% 3.5M
|
Health Technology
|
| O: 1.15%
H: 1.14%
C: -1.71%
pharma drug payment tenapanor hyperphosphatemia application milestone submission
Progress Announces the Recipients of Its 2023 Women in STEM Scholarship Series in the US and Bulgaria; Opens Application Process for India Scholarship
Published: 2023-06-29 (Crawled : 13:20) - globenewswire.com
PRGS S | $50.18 -0.81% -0.82% 540K
|
Technology Services
|
| O: 0.0%
H: 2.71%
C: 2.39%
india women application
European Committee for Orphan Medicinal Products Provides Positive Opinion on INOVIO's Application for Orphan Drug Designation for INO-3107
Published: 2023-04-26 (Crawled : 13:20) - biospace.com/
INO 3 d | $10.22 -7.68% -8.32% 400K
|
Health Technology
|
| O: -0.18%
H: 2.4%
C: -1.56%
ino-3107 drug positive designation application
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
Published: 2023-03-21 (Crawled : 13:20) - biospace.com/
NAOV 4 | $0.75 0.61% 3.5K
|
Health Technology
|
| O: 1.53%
H: 11.72%
C: 6.66%
patent application uroshield
State of Arizona Approves DarkPulse, Inc. Subsidiary, TJM Electronics West, Inc., Trade Name Application for DarkPulse Electronics Manufacturing
Published: 2023-03-21 (Crawled : 13:20) - prnewswire.com
DPLS | $0.001 81.82% 12M
|
Information
|
| O: 0.0%
H: 14.71%
C: 0.0%
state electronics application
aTyr Pharma Announces Phase 2 Study of Efzofitimod in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Following FDA Clearance of IND Application
Published: 2023-03-01 (Crawled : 13:20) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.42%
H: 0.47%
C: -3.74%
fda clearance lung pharma disease application efzofitimod study
City of Brawley, CA Selects PortalGuard® Identity and Access Management Cloud Platform for Enhanced Web Application and Workstation Security
Published: 2023-02-27 (Crawled : 13:20) - globenewswire.com
BKYI | $1.7 -7.02% 14K
|
Technology Services
|
| O: -2.59%
H: 9.67%
C: 6.65%
portalguard management application security platform cloud
Chemomab Announces FDA Clearance of Investigational New Drug Application for Phase 2 Clinical Trial of CM-101 in Patients with Systemic Sclerosis
Published: 2023-02-21 (Crawled : 13:20) - biospace.com/
CMMB | News | $0.629 6.61% 6.2% 30K
|
Manufacturing
|
| O: 23.98%
H: 11.11%
C: -5.76%
cm-101 fda clearance drug application trial sclerosis
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order Application
Published: 2023-02-06 (Crawled : 13:20) - intellipharmaceutics.com
IPCIF | $0.135 -29.49% 16K
|
Health Technology
|
| O: -15.87%
H: 0.0%
C: 0.0%
management order application expected financial
Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO
Published: 2023-01-24 (Crawled : 13:20) - biospace.com/
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: -0.15%
H: 18.49%
C: 15.32%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 0.15%
H: 0.18%
C: -0.48%
candidate application trial approval therapeutics therapy
Blueprint Medicines Announces FDA Acceptance of Supplemental New Drug Application for AYVAKIT® (avapritinib) for the Treatment of Indolent Systemic Mastocytosis
Published: 2023-01-23 (Crawled : 13:20) - prnewswire.com
BPMC | News | $88.9 0.59% 0.58% 730K
|
Health Technology
|
| O: -0.24%
H: 1.29%
C: -0.15%
ayvakit treatment fda drug application
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
Published: 2023-01-23 (Crawled : 13:20) - globenewswire.com
CPRX | $15.35 -4.06% -4.23% 1.4M
|
Health Technology
|
| O: -11.92%
H: 0.49%
C: -19.43%
firdapse pharmaceuticals drug application
2022 Magic Quadrant™ for Enterprise Low-Code Application Platforms by Gartner® Recognizes Mendix as a Leader for Fourth Consecutive time
Published: 2023-01-17 (Crawled : 13:20) - prnewswire.com
IT | News | $449.61 0.07% 0.0% 390K
|
Commercial Services
|
| O: -0.41%
H: 1.07%
C: -0.21%
gartner application
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Published: 2023-01-06 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.0%
H: 1.96%
C: -26.96%
sb206 molluscum treatment fda drug application
Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
Published: 2023-01-04 (Crawled : 13:20) - globenewswire.com
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 6.15%
H: 2.9%
C: 1.45%
CKPT | $1.595 -4.49% -4.7% 470K
|
Health Technology
|
| O: 3.75%
H: 15.7%
C: 4.55%
treatment fda application license therapeutics cell carcinoma cosibelimab
Outlook Therapeutics® Announces Validation of Marketing Authorization Application by the European Medicines Agency for ONS-5010 as a Treatment for Wet AMD
Published: 2022-12-22 (Crawled : 13:20) - globenewswire.com
OTLK P | $8.285 -3.78% -3.92% 230K
|
Health Technology
|
| O: 2.43%
H: 1.12%
C: -1.3%
ons-5010 therapeutics treatment application authorization
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
Published: 2022-12-21 (Crawled : 13:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 6.05%
H: 2.65%
C: 0.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.63%
H: 0.0%
C: 0.0%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.05%
H: 2.34%
C: 1.64%
treatment application diabetes
Global Industrial Laser Market: Analysis By Type ; By Application ; By Region Size, and Trends with Impact of COVID-19 and Forecast up to 2027
Published: 2022-12-20 (Crawled : 13:20) - prnewswire.com
LASR 4 | $10.705 -4.84% -5.09% 390K
|
Electronic Technology
|
| O: -0.42%
H: 5.33%
C: 1.46%
MKSI | $112.16 -2.3% -2.35% 660K
|
Electronic Technology
|
| O: 0.5%
H: 5.18%
C: 3.63%
LITE | $42.44 1.1% 1.08% 1M
|
Producer Manufacturing
|
| O: -2.42%
H: 3.79%
C: 1.78%
IPGP | $84.61 0.28% 0.28% 160K
|
Electronic Technology
|
| O: -0.33%
H: 3.94%
C: 2.33%
COHR | $51.0 -1.56% 0.59% 1.3M
|
Electronic Technology
|
| O: -1.37%
H: 3.33%
C: 1.66%
covid-19 global trends impact application laser
Sage Therapeutics and Biogen Complete Rolling Submission of New Drug Application for Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published: 2022-12-06 (Crawled : 13:20) - biospace.com/
SAGE | $13.03 3.66% 3.53% 1.8M
|
Health Technology
|
| O: -0.25%
H: 0.44%
C: -4.15%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.18%
H: 0.97%
C: -0.26%
treatment drug application therapeutics depression submission major depressive disorder
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.